List view / Grid view
10 May 2016 | By Victoria White, Digital Content Producer
Scientists have designed dozens of molecular “warheads” that can detect a key biomarker of cancer and could be developed into a new class of drug candidates...
10 May 2016 | By Victoria White, Digital Content Producer
We discuss Innate Defense Regulator (IDR) technology with Soligenix's Chief Scientific Officer, Dr Oreola Donini, and find out more about SGX942...
9 May 2016 | By Victoria White, Digital Content Producer
In laboratory tests on human cells and mouse models, an experimental therapy was shown to stop treatment-resistant glioblastoma and high-grade gliomas...
4 May 2016 | By Victoria White, Digital Content Producer
By expressing the genes involved in the production of pleuromutilin in a different type of fungus, researchers increased production by more than 2,000%...
28 April 2016 | By Victoria White, Digital Content Producer
Researchers at Lund University have identified a new therapeutic target for the treatment of bacterial infections that regulates the immune response...
28 April 2016 | By Victoria White, Digital Content Producer
Researchers have shown that zinc-oxide nanoparticles can prevent genital herpes virus from entering cells, and help natural immunity to develop...
25 April 2016 | By Victoria White, Drug Target Review
We've created an infographic on the threat of antibiotic resistance, highlighting some of the recommendations made by the Review on Antimicrobial Resistance to date...
22 April 2016 | By Victoria White, Digital Content Producer
AstraZeneca has launched an integrated genomics initiative to transform drug discovery and development across its entire research and development pipeline...
22 April 2016 | By Victoria White, Digital Content Producer
AbbVie and CytomX Therapeutics have entered into a collaboration to co-develop and co-commercialise Probody Drug Conjugates against CD71...
22 April 2016 | By Victoria White, Digital Content Producer
Key findings show that MM-310 demonstrated superior anti-tumour activity in multiple models compared to free docetaxel...
22 April 2016 | By SMi Group
SMI Reports (12.04.2016): MedImmune Senior Director for R&D to present keynote address on MED10382 at the 3rd Peptides Conference in London...
19 April 2016 | By Victoria White, Digital Content Producer
Evidence is mounting that even mild chronic cold stress in lab mice is skewing results in studies of cancer, inflammation, and more...
19 April 2016 | By Victoria White, Digital Content Producer
Results of a new study could help researchers develop more effective combination therapies and breathe new life into forgotten pancreatic cancer drugs...
19 April 2016 | By Victoria White, Digital Content Producer
New preclinical data show the combination of lenvatinib and everolimus yield greater antitumour activity than either agent alone in kidney cancer...
18 April 2016 | By Victoria White, Digital Content Producer
IPI-549 is an orally administered immuno-oncology development candidate that selectively inhibits phosphoinositide-3-kinase gamma (PI3K-gamma)...
